Melatonin induces autophagy via an mTOR-dependent pathway and enhances clearance of mutant-TGFBIp

Journal of Pineal Research

Volumn 54, Issue 4, 2013, Pages 361-372

  Choi, Seung Il ^a,b   Kim, Kyu Seo ^c   Oh, Jun Young ^a,b   Jin, Jun Yup ^a,b   Lee, Ga Hyun ^a,b   Kim, Eung Kweon ^a,b,d  

^a Corneal Dystrophy Research Institute ^*  (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c DUKE UNIVERSITY   (United States)

^d Yonsei University   (South Korea)

Author keywords

(mTOR); Autophagy; Granular corneal dystrophy type 2; LC3; Melatonin; TGFBIp

Indexed keywords

BAFILOMYCIN A1; BECLIN 1; LUZINDOLE; MAMMALIAN TARGET OF RAPAMYCIN; MELATONIN; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; AVELLINO CORNEAL DYSTROPHY; CELL MATURATION; CONTROLLED STUDY; CORNEA DYSTROPHY; DRUG POTENTIATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN DEGRADATION;

(MTOR); AUTOPHAGY; GRANULAR CORNEAL DYSTROPHY TYPE 2; LC3; MELATONIN; TGFBIP;

ANIMALS; AUTOPHAGY; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; HUMANS; MELATONIN; MICROSCOPY, ELECTRON, TRANSMISSION; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84879464170     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12039     Document Type: Article

References (92)

1. MUNIER FL, KORVATSKA E, DJEMAI A et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997; 15:247-251.
2. SKONIER J, NEUBAUER M, MADISEN L et al. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 1992; 11:511-522.
3. KLINTWORTH GK. Advances in the molecular genetics of corneal dystrophies. Am J Ophthalmol 1999; 128:747-754.
4. KORVATSKA E, HENRY H, MASHIMA Y et al. Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J Biol Chem 2000; 275:11465-11469.
5. ZHAO Y, SHAO G, PIAO CQ et al. Down-regulation of Betaigh3 gene is involved in the tumorigenesis in human bronchial epithelial cells induced by heavy-ion radiation. Radiat Res 2004; 162:655-659.
6. ZHAO YL, PIAO CQ, HEI TK. Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells. Oncogene 2002; 21:7471-7477.
7. ZHANG Y, WEN G, SHAO G et al. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res 2009; 69:37-44.
8. LEBARON RG, BEZVERKOV KI, ZIMBER MP et al. Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 1995; 104:844-849.
9. BILLINGS PC, HERRICK DJ, KUCICH U et al. Extracellular matrix and nuclear localization of beta ig-h3 in human bladder smooth muscle and fibroblast cells. J Cell Biochem 2000; 79:261-273.
10. KIM JE, JEONG HW, NAM JO et al. Identification of motifs in the fasciclin domains of the transforming growth factor-betainduced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem 2002; 277:46159-46165.
11. KLIONSKY DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8:931-937.
12. NAKAGAWA I, AMANO A, MIZUSHIMA N et al. Autophagy defends cells against invading group a Streptococcus. Science 2004; 306:1037-1040.
13. PALUDAN C, SCHMID D, LANDTHALER M et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005; 307:593-596.
14. ENGLISH L, CHEMALI M, DURON J et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009; 10:480-487.
15. TSUKAMOTO S, KUMA A, MURAKAMI M et al. Autophagy is essential for preimplantation development of mouse embryos. Science 2008; 321:117-120.
16. FIMIA GM, STOYKOVA A, ROMAGNOLI A et al. Ambra1 regulates autophagy and development of the nervous system. Nature 2007; 447:1121-1125.
17. SINGH R, KAUSHIK S, WANG YJ et al. Autophagy regulates lipid metabolism. Nature 2009; 458:1131-1135.
18. HARA T, NAKAMURA K, MATSUI M et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-889.
19. LEVINE B, KROEMER G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42.
20. RENNA M, JIMENEZ-SANCHEZ M, SARKAR S et al. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 2010; 285:11061-11067.
21. FORTUN J, DUNN WA Jr, JOY S et al. Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 2003; 23:10672-10680.
22. BERGER Z, RAVIKUMAR B, MENZIES FM et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 2006; 15:433-442.
23. KABUTA T, SUZUKI Y, WADA K. Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J Biol Chem 2006; 281:30524-30533.
24. REITER RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12:151-180.
25. DOMINGUEZ-RODRIGUEZ A, ABREU-GONZALEZ P, SANCHEZSANCHEZ JJ et al. Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010; 49:14-22.
26. LALIENA A, SAN MIGUEL B, CRESPO I et al. Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. J Pineal Res 2012; 53:270-278.
27. JUNG-HYNES B, REITER RJ, AHMAD N. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010; 48:9-19.
28. GIRGERT R, HANF V, EMONS G et al. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J Pineal Res 2009; 47:23-31.
29. BEJARANO I, REDONDO PC, ESPINO J et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46:392-400.
30. TAN D, CHEN L, POEGGELER B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
31. GALANO A, TAN DX, REITER RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51:1-16.
32. HARDELAND R, TAN DX, REITER RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47:109-126.
33. RESSMEYER AR, MAYO JC, ZELOSKO V et al. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003; 8:205-213.
34. RODRIGUEZ C, MAYO JC, SAINZ RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
35. PABLOS MI, AGAPITO MT, GUTIERREZ R et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995; 19:111-115.
36. SUN FY, LIN X, MAO LZ et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 2002; 33:48-56.
37. YOO YM, YIM SV, KIM SS et al. Melatonin suppresses NOinduced apoptosis via induction of Bcl-2 expression in PGTbeta immortalized pineal cells. J Pineal Res 2002; 33:146-150.
38. JOU MJ, PENG TI, HSU LF et al. Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2 + )-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010; 48:20-38.
39. PARADIES G, PETROSILLO G, PARADIES V et al. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48:297-310.
40. CHOI SI, JOO SS, YOO YM. Melatonin prevents nitric oxide-induced apoptosis by increasing the interaction between 14-3-3beta and p-Bad in SK-N-MC cells. J Pineal Res 2008; 44:95-100.
41. BRYDON L, BARRETT P, MORGAN PJ et al. Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies. Adv Exp Med Biol 1999; 460:215-220.
42. DUBOCOVICH ML, MASANA MI, BENLOUCIF S. Molecular pharmacology and function of melatonin receptor subtypes. Adv Exp Med Biol 1999; 460:181-190.
43. RADA JA, WIECHMANN AF. Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation. Invest Ophthalmol Vis Sci 2006; 47:25-33.
44. MEYER P, PACHE M, LOEFFLER KU et al. Melatonin MT-1-receptor immunoreactivity in the human eye. Br J Ophthalmol 2002; 86:1053-1057.
45. SIU AW, MALDONADO M, SANCHEZ-HIDALGO M et al. Protective effects of melatonin in experimental free radical-related ocular diseases. J Pineal Res 2006; 40:101-109.
46. ROSENSTEIN RE, PANDI-PERUMAL SR, SRINIVASAN V et al. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis. J Pineal Res 2010; 49:1-13.
47. YI C, PAN X, YAN H et al. Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci 2005; 1057:384-392.
48. SANCHEZ-BARCELO EJ, MEDIAVILLA MD, TAN DX et al. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010; 17:2070-2095.
49. CHOI SI, KIM BY, DADAKHUJAEV S et al. Impaired autophagy and delayed autophagic clearance of transforming growth factor beta-induced protein (TGFBI) in granular corneal dystrophy type 2. Autophagy 2012; 8:1782-1797.
50. COTO-MONTES A, BOGA JA, ROSALES-CORRAL S et al. Role of melatonin in the regulation of autophagy and mitophagy: a review. Mol Cell Endocrinol 2012; 361:12-23.
51. VEGA-NAREDO I, CABALLERO B, SIERRA V et al. Melatonin modulates autophagy through a redox-mediated action in female Syrian hamster Harderian gland controlling cell types and gland activity. J Pineal Res 2012; 52:80-92.
52. CHOI SI, KIM TI, KIM KS et al. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am J Pathol 2009; 175:248-261.
53. KIM TI, KIM H, LEE DJ et al. Altered mitochondrial function in type 2 granular corneal dystrophy. Am J Pathol 2011; 179:684-692.
54. CIPOLAT S, MARTINS DE BRITO O, DAL ZILIO B et al. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci U S A 2004; 101:15927-15932.
55. BLOMMAART EF, LUIKEN JJ, MEIJER AJ. Autophagic proteolysis: control and specificity. Histochem J 1997; 29:365-385.
56. SEGLEN PO, BOHLEY P. Autophagy and Other Vacuolar Protein-Degradation Mechanisms. Experientia 1992; 48:158-172.
57. YAMAMOTO A, TAGAWA Y, YOSHIMORI T et al. Bafilomycin A (1) prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 1998; 23:33-42.
58. PATTINGRE S, ESPERT L, BIARD-PIECHACZYK M et al. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 2008; 90:313-323.
59. CHEN Y, AZAD MB, GIBSON SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ 2009; 16:1040-1052.
60. GRIPARIC L, VAN DER WEL NN, OROZCO IJ et al. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 2004; 279:18792-18798.
61. MIZUSHIMA N, LEVINE B, CUERVO AM et al. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069 -1075.
62. TERMAN A, GUSTAFSSON B, BRUNK UT. Autophagy, organelles and ageing. J Pathol 2007; 211:134-143.
63. CIECHANOVER A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 2005; 6:79-87.
64. FINKBEINER S, CUERVO AM, MORIMOTO RI et al. Diseasemodifying pathways in neurodegeneration. J Neurosci 2006; 26:10349-10357.
65. SARKAR S, FLOTO RA, BERGER Z et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005; 170:1101-1111.
66. TODDE V, VEENHUIS M, VAN DER KLEI IJ. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 2009; 1792:3-13.
67. KONDO Y, KANZAWA T, SAWAYA R et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-734.
68. QU X, YU J, BHAGAT G et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809-1820.
69. SHINTANI T, KLIONSKY DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306:990-995.
70. LIANG XH, JACKSON S, SEAMAN M et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-676.
71. BHASKAR PT, HAY N. The two TORCs and Akt. Dev Cell 2007; 12:487-502.
72. WULLSCHLEGER S, LOEWITH R, HALL MN. TOR signaling in growth and metabolism. Cell 2006; 124:471-484.
73. NOPPARAT C, PORTER JE, EBADI M et al. The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy. J Pineal Res 2010; 49:382-389.
74. YOO YM, JEUNG EB. Melatonin suppresses cyclosporine A-induced autophagy in rat pituitary GH3 cells. J Pineal Res 2010; 48:204-211.
75. ZHOU H, CHEN J, LU X et al. Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells. J Pineal Res 2012; 52:120-127.
76. JEONG JK, MOON MH, LEE YJ et al. Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J Pineal Res 2012; 53:138-146.
77. YUE Z, JIN S, YANG C et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003; 100:15077-15082.
78. XUE L, FLETCHER GC, TOLKOVSKY AM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 1999; 14:180-198.
79. DAIDO S, KANZAWA T, YAMAMOTO A et al. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 2004; 64:4286-4293.
80. BJORNSTI MA, HOUGHTON PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 2004; 4:335-348.
81. ANDRABI SA, SAYEED I, SIEMEN D et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 2004; 18:869-871.
82. RADOGNA F, CRISTOFANON S, PATERNOSTER L et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008; 44:316-325.
83. CHOI SI, DADAKHUJAEV S, RYU H et al. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J Pineal Res 2011; 51:94-103.
84. MASSEY AC, ZHANG C, CUERVO AM. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 2006; 73:205-235.
85. CUERVO AM, DICE JF. Age-related decline in chaperone-mediated autophagy. J Biol Chem 2000; 275:31505-31513.
86. CUERVO AM, KNECHT E, TERLECKY SR et al. Activation of a Selective Pathway of Lysosomal Proteolysis in Rat-Liver by Prolonged Starvation. Am J Physiol Cell Physiol 1995; 269: C1200-C1208.
87. MELCHIORRI D, REITER RJ, ATTIA AM et al. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1995; 56:83-89.
88. AZAD MB, CHEN Y, GIBSON SB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal 2009; 11:777-790.
89. HUANG J, LAM GY, BRUMELL JH. Autophagy signaling through reactive oxygen species. Antioxid Redox Signal 2011; 14:2215-2231.
90. BLASK DE, SAUER LA, DAUCHY RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadianbased cancer therapy. Curr Top Med Chem 2002; 2:113-132.
91. ZHAO YL, PIAO CQ, HEI TK. Overexpression of Betaig-h3 gene downregulates integrin alpha5beta1 and suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells. Br J Cancer 2002; 86:1923-1928.
92. ZHAO Y, EL-GABRY M, HEI TK. Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells. Mol Carcinog 2006; 45:84-92.